Timber Hill’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-44,893
Closed -$3.38M 147
2018
Q1
$3.38M Buy
44,893
+7,752
+21% +$616K 0.52% 40
2017
Q4
$2.66M Buy
+37,141
New +$2.82M 0.17% 130
2017
Q2
Sell
-31,318
Closed -$2.08M 1265
2017
Q1
$2.13M Buy
31,318
+28,359
+958% +$1.99M 0.02% 677
2016
Q4
$212K Buy
+2,959
New +$220K ﹤0.01% 2053
2015
Q4
Sell
-36,845
Closed -$3.83M 2320
2015
Q3
$3.62M Buy
36,845
+20,802
+130% +$2.31M 0.02% 703
2015
Q2
$1.88M Sell
16,043
-1,632
-9% -$178K 0.01% 1103
2015
Q1
$1.73M Sell
17,675
-10,328
-37% -$1.05M 0.01% 1109
2014
Q4
$2.64M Buy
+28,003
New +$2.9M 0.01% 865
2014
Q2
Sell
-58,249
Closed -$4.53M 2827
2014
Q1
$4.13M Buy
58,249
+25,716
+79% +$2.02M 0.02% 734
2013
Q4
$2.44M Sell
32,533
-59,326
-65% -$4.13M 0.01% 1231
2013
Q3
$5.78M Buy
+91,859
New +$5.49M 0.02% 761

Other funds holding GILD

Timber Hill's GILD Position: Q2 2018 in Review

Timber Hill sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 44,893 shares — an estimated $3.38M sold.

Timber Hill first reported a position in GILD in Q3 2013 and held it in 11 quarters. The position peaked at $5.78M in Q3 2013. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Timber Hill reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 44,893 Gilead Sciences shares in Q2 2018, an estimated $3.38M.
  • Timber Hill first reported a position in Gilead Sciences in Q3 2013 and held it in 11 quarters.
  • Timber Hill's Gilead Sciences position peaked at $5.78M in Q3 2013.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.